Headlines Preclinical-Research 
pharmaphorum
JUNE 1, 2022
For Astellas, GO will discover high-affinity antibodies against the O-glycoprotein targets, with the Japanese drugmaker responsible for subsequent research activities, clinical development and commercialisation if they reach the market.
pharmaphorum
DECEMBER 21, 2020
Each programme includes undisclosed upfront and milestone payments plus royalties on sales, with Merck indicating in a statement that it will be funding the research. The headline of the deal was an experimental COVID-19 drug, but it also claimed rights to a pipeline of early-stage oncology drugs. Other recent deals include a $2.8
Pharmaceutical Technology
MARCH 6, 2023
For a long time, aging biology and research have been enigmatic areas that biotechs hoped to capitalise on due to their market potential. Kohanski emphasised that researchers at the institute approach their work by focusing on “healthy aging” rather than “anti-aging.”
Expert insights. Personalized for you.
98 
Let's personalize your content